The reported effect size of TREM2 variants on AD risk has varied in the literature [96, 155]: some investigations estimate an odds ratio of 3–4 (similar to the risk of carrying a single Apoε4 allele), while others show only a small to moderate effect [96, 151, 155, 157]. This evidence concerns the gene APOE and Alzheimer disease.